Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NTRB is expected to report earnings to rise 171.43% to -18 cents per share on December 07
Q4'26
Est.
$-0.19
Q3'26
Beat
by $0.09
Q1'26
Est.
$-1.89
Q4'25
Beat
by $1.81
Q3'25
Missed
by $1.95
The last earnings report on September 30 showed earnings per share of -7 cents, beating the estimate of -15 cents. With 58.42K shares outstanding, the current market capitalization sits at 84.16M.